Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:43 AM
Ignite Modification Date:
2025-12-25 @ 4:43 AM
NCT ID:
NCT03905018
Eligibility Criteria:
Inclusion Criteria:
* Male patients
* Age 25 to 60 years
* Obesity grade I-II
* .Sign the inform consent form.
* Answer the questionary IIFE
Exclusion Criteria:
. DM 1-2
* Systemic arterial hypertension
* Uncontrolled Mixed Dyslipidemia or under Hypolipemiant Treatment with statins.
* Active smoking
* Precedent of uncontrolled Ischemic cardiopathy.
* Use of anti-inflammatory drugs, including Acetylsalicylic acid, antihypertensive, antihyperglucemic, anti-anginal drugs, recent use of antiviral drugs that contains vasoconstrictors.
* Hepatic, renal, thyroid, and/or pulmonary decompensated disease.
* The precedent of hypersensibility to the phosphodiesterase-5 inhibitors.
* Patients that are under treatmen with iPDE
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
25 Years
Maximum Age:
60 Years
Study:
NCT03905018
Study Brief:
Protocol Section:
NCT03905018